| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Alx Oncology Holdings Inc. (ALXO) have been net sellers, shedding 2,803 shares worth roughly $5K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.45M | $10.90M | - | |
| CEO | 294.4K | $379.7K | - | |
| VP | 87.8K | $113.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2021 | Jaume Pons89 | President & CEO | Sell | 16,700 | $55.71 | $930,276.00 | -3.1% | +23.3% | -84.2% | |
| May 10, 2021 | Sophia Randolph88 | Chief Medical Officer | Sell | 7,387 | $61.97 | $457,771.58 | -3.8% | +5.8% | -84.1% | |
| Apr 19, 2021 | Jaume Pons89 | President & CEO | Sell | 16,700 | $57.63 | $962,433.39 | -3.0% | -2.5% | -72.4% | |
| Apr 12, 2021 | Sophia Randolph88 | Chief Medical Officer | Sell | 7,387 | $59.43 | $438,977.74 | -3.7% | -5.5% | -70.3% | |
| Mar 22, 2021 | Jaume Pons89 | President and CEO | Sale+OE | 16,700 | $68.49 | $1,143,860.49 | -2.9% | -15.5% | -73.0% | |
| Mar 10, 2021 | Sophia Randolph88 | Chief Medical Officer | Sell | 7,387 | $74.34 | $549,173.18 | -3.5% | -20.7% | -74.9% | |
| Dec 14, 2020 | G. Walmsley Graham48 | Director | Buy | 20,000 | $76.00 | $1,520,000.00 | +2.1% | - | - | |
| Jul 21, 2020 | Lsv Associates, LLC78 | 10% Owner | Buy | 400,000 | $19.00 | $7,600,000.00 | -105.8% | - | - | |
| Jul 21, 2020 | Peter S Garcia81 | Chief Financial Officer | Buy | 3,000 | $19.00 | $57,000.00 | New | - | - | |
| Jul 21, 2020 | Steffen Pietzke | VP Fin & Chief Acct Officer | Buy | 3,000 | $19.00 | $57,000.00 | New | - | - |